ArticleBone marrow transplantation2017

Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.

S Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.